TLR4 and metabolic dysfunction-associated steatotic liver disease: It has been suggested that phosphatidylcholine may improve intestinal barrier function21,22 and that an increased intestinal translocation of LPS leading to an activation of TLR4 and subsequently an activation of nuclear factor κ-light-chain enhancer of activated B cells (NFκB)-dependent signaling may be critical in the development of MASLD.7